Population
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) modeling hypertrophic cardiomyopathy
Design
Preclinical
Authors
Loading...
These mechanisms suggest arrhythmia targets in HCM models; leaves open clinical translation pending human studies.
CRISPR/Cas9-engineered hPSC-CMs reveal that energy depletion, arrhythmias, and hypocontractility are key mechanisms and potential therapeutic targets in hypertrophic cardiomyopathy.
Mosqueira et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: